Glucocorticoids: The Debate Continues Déjà vu … In past decades, rheumatologists have seen, heard, practiced and taught much of what has been argued in the “ongoing debate” on the use of glucocorticoids (GCs) in the management of rheumatoid arthritis (RA).1 It is heartening to note that eminent professors have stuck to their premise all these…
Search results for: glucocorticoid
Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate
Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists
Glucocorticoid Found to Increase Bone Mineral Density in Mouse Study
Recent research suggests the lymphocyte-suppressive effect of dexamethasone may underlie the glucocorticoid’s effect on building trabecular bone density
New Assay Aids In Evaluating Metabolic Effects of Glucocorticoids
Test measures efficacy of compounds for treating arthritis and their effect on glucose kinetics
Glucocorticoids a Fracture Risk at Any Dose
Updated recommendations advocate doing more to determine fracture risk and the need for preventive therapy
The Evolution of Glucocorticoids
Hench lecturer highlights complexities of these steroid hormones’ signaling mechanisms
Glucocorticoid-Induced Osteoporosis
Osteoporosis is a condition of weak bone caused by a loss of bone mass and a change in bone structure. Glucocorticoid-induced osteoporosis is a form of osteoporosis caused by taking glucocorticoid medications, such as prednisone (Deltasone, Orasone, etc.), prednisolone (Prelone), dexamethasone (Decadron, Hexadrol), and cortisone (Cortone Acetate). These medications are used to help control many rheumatic diseases, including RA, systemic lupus erythematosus, and polymyalgia rheumatica.
FDA Approves New Biosimilars to Denosumab with an Interchangeable Designation
The FDA has approved the first interchangeable biosimilars for denosumab.
Optimizing DMARD Use in Older Adults with Rheumatoid Arthritis
SAN DIEGO—Older adults with rheumatoid arthritis (RA) comprise two groups: those who have lived with diagnosed RA since an early age (young-onset RA) and those who have new-onset RA diagnosed at an older age (≥65 years), known as late-onset RA or, formerly, as elderly onset RA.1 Individuals with late-onset RA have more acute and systemic…
SMILE, an Online Lupus Tool, Can Aid Shared Decision Making
Patients with systemic lupus erythematosus (SLE) often face many concerns, fears and uncertainties that render “treatment decision making very difficult,” says Jasvinder Singh, MD, MPH, professor of medicine and epidemiology at the University of Alabama at Birmingham. Often these patients, who tend to be women from minority groups, “do not have access to easily understandable…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 50
- Next Page »